These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 27156843)

  • 21. The Availability and Acquisition of Illicit Anabolic Androgenic Steroids and Testosterone Preparations on the Internet.
    McBride JA; Carson CC; Coward RM
    Am J Mens Health; 2018 Sep; 12(5):1352-1357. PubMed ID: 27170675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings.
    Frati P; Busardò FP; Cipolloni L; Dominicis ED; Fineschi V
    Curr Neuropharmacol; 2015 Jan; 13(1):146-59. PubMed ID: 26074749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters.
    Scarth M; Westlye LT; Havnes IA; Bjørnebekk A
    BMC Psychiatry; 2023 May; 23(1):342. PubMed ID: 37193971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outpatient clinic for users of anabolic androgenic steroids: an overview.
    Smit DL; de Ronde W
    Neth J Med; 2018 May; 76(4):167. PubMed ID: 29845939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse health effects of anabolic-androgenic steroids.
    van Amsterdam J; Opperhuizen A; Hartgens F
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):117-23. PubMed ID: 20153798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10,365 general population men.
    Lundholm L; Frisell T; Lichtenstein P; Långström N
    Addiction; 2015 Jan; 110(1):100-8. PubMed ID: 25170826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men.
    Sharma A; Grant B; Islam H; Kapoor A; Pradeep A; Jayasena CN
    Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101691. PubMed ID: 35999138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of the Online Market for Anabolic-Androgenic Steroids in Central Asia: A Netnographic Analysis.
    Nyssanbayeva K; Abdulla V; Semenova Y; Bakasheva M; Sagoe D; Glushkova N
    Subst Use Misuse; 2024; 59(1):10-19. PubMed ID: 37724019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human growth hormone abuse in male weightlifters.
    Brennan BP; Kanayama G; Hudson JI; Pope HG
    Am J Addict; 2011; 20(1):9-13. PubMed ID: 21175915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.
    Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
    Pharmacotherapy; 2011 Aug; 31(8):757-66. PubMed ID: 21923602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early myocardial dysfunction after chronic use of anabolic androgenic steroids: combined pulsed-wave tissue Doppler imaging and ultrasonic integrated backscatter cyclic variations analysis.
    Montisci R; Cecchetto G; Ruscazio M; Snenghi R; Portale A; Viel G; Nalesso A; Paoli A; Iliceto S; Meloni L; Ferrara SD; Montisci M
    J Am Soc Echocardiogr; 2010 May; 23(5):516-22. PubMed ID: 20381311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of anabolic androgenic steroids on male sexual and reproductive function: a systematic review.
    Esposito M; Salerno M; Calvano G; Agliozzo R; Ficarra V; Sessa F; Favilla V; Cimino S; Pomara C
    Panminerva Med; 2023 Mar; 65(1):43-50. PubMed ID: 35146992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and Management of Anabolic Androgenic Steroid Use.
    Anawalt BD
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2490-2500. PubMed ID: 30753550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotoxicity by synthetic androgen steroids: oxidative stress, apoptosis, and neuropathology: A review.
    Pomara C; Neri M; Bello S; Fiore C; Riezzo I; Turillazzi E
    Curr Neuropharmacol; 2015 Jan; 13(1):132-45. PubMed ID: 26074748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Theory of mind in users of anabolic androgenic steroids.
    Vaskinn A; Hauger LE; Bjørnebekk A
    Psychopharmacology (Berl); 2020 Oct; 237(10):3191-3199. PubMed ID: 32623552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of anabolic-androgens on brain reward function.
    Mhillaj E; Morgese MG; Tucci P; Bove M; Schiavone S; Trabace L
    Front Neurosci; 2015; 9():295. PubMed ID: 26379484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anabolic steroids: a fatal attraction?
    Wood RI
    J Neuroendocrinol; 2006 Mar; 18(3):227-8. PubMed ID: 16454806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct interactions of androgenic/anabolic steroids with the peripheral benzodiazepine receptor in rat brain: implications for the psychological and physiological manifestations of androgenic/anabolic steroid abuse.
    Masonis AE; McCarthy MP
    J Steroid Biochem Mol Biol; 1996 Aug; 58(5-6):551-5. PubMed ID: 8918981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multisubstance use as a feature of addiction to anabolic-androgenic steroids.
    Skarberg K; Nyberg F; Engstrom I
    Eur Addict Res; 2009; 15(2):99-106. PubMed ID: 19182484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Illicit anabolic-androgenic steroid use.
    Kanayama G; Hudson JI; Pope HG
    Horm Behav; 2010 Jun; 58(1):111-21. PubMed ID: 19769977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.